Zimmer fails to get FDA panel's support for Dynesys implant
An FDA panel voted against recommending Zimmer Holdings' Dynesys implant because studies failed to clearly demonstrate the safety and efficacy of the device in treating a spinal problem. A company official said Zimmer's data "demonstrated a reasonable assurance of safety and effectiveness" of the titanium implant.
Times-Picayune (New Orleans), The | 11/04
This story published in AdvaMed SmartBrief on 11/05/2009
More from SmartBrief:
Orthopedic implant maker to publicly offer $1B in senior notes
Friday, November 13, 2009
Tax proposal, recession threaten orthopedic sector's growth
Wednesday, October 14, 2009
Zimmer stops operation of device facility in Indiana due to fire
Friday, September 4, 2009
Get stories like these delivered daily for FREE:
|
AdvaMed SmartBrief
Designed specifically for manufacturers of medical devices, health care information systems and diagnostic products, AdvaMed SmartBrief is a FREE e-mail newsletter. By providing a summary of the day's most important medical technologies news, AdvaMed SmartBrief saves you time and keeps you smart. Learn more |
|